- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01505738
Bacterial Growth in Vascular Surgery Wounds
December 13, 2012 updated by: Sanna Kouhia, North Karelia Central Hospital
The Effect of Bacterial Growth in Vascular Surgery Wounds to the Incidence of Postoperative Wound Infections
The amount and species of bacteria have been shown to have an effect in wound infections in several fields of surgery (such as gastrointestinal and orthopaedic surgery and the surgery of facial area).
In vascular surgery, wound infections are a common and expensive complication.
The aim of the present study is to investigate the prevalence of bacteria in vascular surgery wounds perioperatively, and determine whether is correlates with the incidence of wound infections postoperatively.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Joensuu, Finland, FIN-80210
- North Karelia Central Hospital, Clinic of Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
100 patients requiring lower limb vascular surgery due to ischaemic changes and/or lower limb aneurysms.
Description
Inclusion Criteria:
- need for lower limb vascular by-pass surgery
Exclusion Criteria:
- allergic to cefuroxime
- patients refusal to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
bacterial cultures
Bacterial samples are collected preoperatively from urine, nose and possible lower limb ischaemic wounds, perioperatively from inguinal area and wound edges, and twice postoperatively.
In addition, in case of a wound infection, bacterial samples are taken for diagnosis as usual.
|
bacterial samples taken
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
wound infection
Time Frame: 3 months
|
incidence of wound infection after lower limb vascular surgery
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
January 4, 2012
First Submitted That Met QC Criteria
January 5, 2012
First Posted (Estimate)
January 6, 2012
Study Record Updates
Last Update Posted (Estimate)
December 17, 2012
Last Update Submitted That Met QC Criteria
December 13, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NKCH-Surg-009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysm
-
University of BolognaCompletedThoracoabdominal Aortic Aneurysm | Ruptured Thoracic Aneurysm | Ruptured Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm, RupturedItaly
-
W.L.Gore & AssociatesCMIC Co, Ltd. JapanRecruitingThoracoabdominal Aortic Aneurysm | Pararenal Aortic AneurysmJapan
-
Karolinska University HospitalKarolinska Institutet; Swedish Heart Lung FoundationActive, not recruitingAortic Aneurysm | Aortic Aneurysm Abdominal | Abdominal AneurysmSweden
-
University of North Carolina, Chapel HillCook Group Incorporated; UNC HospitalsEnrolling by invitationAortic Aneurysm, Abdominal | Aortic Arch Aneurysm | Ascending Aorta AneurysmUnited States
-
IRCCS San RaffaeleCompletedAneurysm Thoracic | Aneurysm Abdominal | Renal AneurysmUnited States, France, Italy, United Kingdom, Germany, Spain, Denmark, Sweden
-
CEVARIIUniversity of Colorado, Denver; University of Copenhagen; University of Iowa; University... and other collaboratorsEnrolling by invitationComplex EVAR in Inflammatory and Infective Abdominal and Thoracoabdominal Aortic Aneurysms (CEVARII)Abdominal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Aneurysm, Infected | Inflammatory Abdominal Aortic Aneurysm | Aneurysm, MycoticUnited States
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal AneurysmUnited States
-
Karolinska University HospitalEnrolling by invitationAneurysm | Aortic Aneurysm | Abdominal Aortic Aneurysm, Ruptured | Aneurysm Abdominal | Abdominal Aortic Aneurysm Without RuptureSweden
-
IRCCS San RaffaeleCompletedAneurysm | Aneurysm Thoracic | Aneurysm Abdominal | Aneurysm, Thoracoabdominal AorticItaly
-
University Hospital of LimerickCompleted
Clinical Trials on bacterial samples
-
Centre Hospitalier Universitaire de Saint EtienneCompletedStaphylococcus AureusFrance
-
Hospices Civils de LyonCompleted
-
Barzilai Medical CenterUnknownOral Squamous Cell Carcinoma | Medication Related Osteonecrosis of the Jaw | Oral Epithelial DysplasiaIsrael
-
Cumberland PharmaceuticalsTerminatedGram-Positive Bacterial InfectionsUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedHelicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)Helicobacter Pylori Infection | Helicobacter Pylori gyrA Levofloxacin Resistance Mutation | Fecal Drug Resistance Gene Detection | Helicobacter Pylori Infection, Susceptibility toChina
-
Centre Georges Francois LeclercINSERM U866 Faculté de Médecine et PharmacieCompleted
-
Centre Hospitalier Universitaire DijonCompletedPrimary Immune Thrombocytopenia (ITP)France
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPaediatric MalignanciesFrance
-
Tel-Aviv Sourasky Medical CenterUnknownBlood Antibiotic Levels
-
Meyer Children's Hospital IRCCSRecruiting